Intercell AGVienna Austria
Company Description
Intercell AG really wants give the pharmaceutical industry a shot in the arm. The Austrian company develops new vaccinations that aim to invoke strong immune system responses. It sells a travelers vaccine for Japanese encephalitis in areas of Europe, the Asia/Pacific region, and North America. Vaccine development candidates aim to fight staph infections, pandemic influenza, hepatitis C, and other viral and bacterial infections. The company also develops antibody (protein) therapies. Intercell has commercial licensing and co-development agreements with larger companies, including
| Campus Vienna Biocenter 3 | Phone: +43-1-20620-0 | |
| Vienna 1030 | Fax: +43-1-20620-800 | 
Map This Company |
| Austria |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Intercell AG Rankings
Executives
| 15 executives listed for Intercell AG's Vienna, Austria location. | ||
| Chairman | Michel Gréco | |
|---|---|---|
| Vice Chairman | Ernst-Günter Afting | |
| CEO | Gerd Zeittlmeissl | |
Financials
| Company Type | Public - Vienna: ICLL Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 408 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Intercell AG now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
